Camp4 Therapeutics Ownership & Insider Activity

Camp4 Therapeutics (CAMP) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 1.3% of shares outstanding. Institutional investors hold 15.0%. Over the past 90 days, insiders made 5 purchases worth $99K and 4 sales worth $2.5M.

Shares Outstanding

62.753M

Shares Float

45.982M

Insider Shares Owned

799.607K

Insider % Owned

1.3%

Institutional Shares Held

9.405M

Institutional % Held

15.0%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

$99K total

Sales (90d)

$2.5M total

Net Activity

Net Selling

Net Value (90d)

-$2.4M

Camp4 Therapeutics Insider Transactions (Last 6 Months)

すべてのインサイダー取引を見る →

Date	Insider	Title	Type	Shares	Price	Value
Aug 31, 2026	Kelly Gold	CHIEF FINANCIAL OFFICER	BUY	10.000K	$3.96	$40K
Aug 27, 2026	Andrew J Schwab	—	SELL	400.000K	$4.04	$1.6M
Aug 24, 2026	Andrew J Schwab	—	SELL	10.000	$4.50	$45
Aug 19, 2026	Andrew J Schwab	—	SELL	191.865K	$4.59	$880K
Aug 19, 2026	Daniel Tardiff	CHIEF SCIENTIFIC OFFICER	SELL	1.738K	$4.76	$8K
Aug 3, 2026	Richard Young	DIRECTOR	BUY	16.378K	$1.65	$27K
Aug 3, 2026	Yuri Maricich	CHIEF MEDICAL OFFICER	BUY	6.551K	$1.65	$11K
Aug 3, 2026	Kelly Gold	CHIEF FINANCIAL OFFICER	BUY	6.551K	$1.65	$11K
Aug 3, 2026	Josh MandelBrehm	CHIEF EXECUTIVE OFFICER	BUY	6.551K	$1.65	$11K

More with Benzinga EdgeGet Access

Camp4 Therapeutics Corp

ニュース

パートナーシップ

ベンジンガ・グローバル

Camp4 Therapeutics Ownership & Insider Activity

Camp4 Therapeutics Insider Transactions (Last 6 Months)

People Also Watch

People Also Watch